ELUTIA INC. — Director's Dealing 2020

Oct 8, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AZIYO BIOLOGICS, INC. (AZYO)
CIK: 0001708527
Period of Report: 2020-10-07

Reporting Person: Riebman Jerome (Chief Medical Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$10.3266	2027-01-21	Class A Common Stock (15765)		Direct

Footnotes

F1: This option vests as to 25% of the underlying shares on January 22, 2021 and in 12 equal quarterly installments thereafter, such that the option shall be fully vested and exercisable on April 22, 2024.